Karo Pharma AB - Company Profile

Powered by

All the data and insights you need on Karo Pharma AB in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Karo Pharma AB Strategy Report

  • Understand Karo Pharma AB position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Karo Pharma AB: Overview

Select Item

Karo Healthcare AB (Karo Healthcare), formerly Karo Pharma AB, is a healthcare company which focuses on development and commercialization of pharmaceutical products. The company provides prescription medicines and over the counter products to pharmacies and directly to the healthcare sector across various countries with the Nordic region and Europe as its core markets. Karo Pharma has developed BabySlide, a product that is developed to reduce stretch marks during childbirth. The company has brands spanning six key categories which include intimate care, dermatology, foot care, wellness, Rx pharma care, pain, cough & cold. Karo Pharma AB is headquartered in, Stockholm, Sweden.

 Gain a 360-degree view of Karo Pharma AB and make more informed decisions for your business Gain a 360-degree view of Karo Pharma AB and make more informed decisions for your business Find out more
Headquarters Sweden
Address Klara Norra Kyrkogata 33, Stockholm, 11122
Website www.karopharma.se
Telephone 46 8 4443820
No of Employees 369
Industry Pharmaceuticals and Healthcare
Revenue (2022) $409.2M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Karo Pharma AB premium industry data and analytics

30+

Clinical Trials

Determine Karo Pharma AB go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Karo Pharma AB’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Marketed Drugs

Understand Karo Pharma AB’s commercialized product portfolio to stay one step ahead of the market.

17+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Karo Pharma AB’s relevant decision makers and contact details.

5

Catalyst Calendar

Proactively evaluate Karo Pharma AB’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Therapy Areas: Decubal
Dermatology Oliva
Intimate Care Fungobase
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Karo Pharma AB portfolio and identify potential areas for collaboration Understand Karo Pharma AB portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Others In November, the company's application for de-listing was approved by Nasdaq.
2022 Acquisitions/Mergers/Takeovers In April, the company completed the acquisition of E45 from Reckitt for GBP200 million.
2022 Contracts/Agreements In March, the company agreed to acquire assets of Del Decus Enterprises.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Karo Pharma AB Genmab AS BioInvent International AB Active Biotech AB Amgen Research Copenhagen
Headquarters Sweden Denmark Sweden Sweden Denmark
City Stockholm Koebenhavn V Lund Lund Copenhagen
No. of Employees 369 2,204 111 11 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Patrick Smallcombe Chairman Executive Board 2021 60
Christoffer Lorenzen Chief Executive Officer Senior Management 2019 48
Jon Johnsson Chief Financial Officer Senior Management 2019 48
Anna Hale Chief Marketing Officer Senior Management 2021 48
Michael Kaltenborn Chief Strategy and Corporate Development Officer Senior Management 2023 49
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Karo Pharma AB key executives to enhance your sales strategy Gain insight into Karo Pharma AB key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward